No actionable signal. The cluster is too small to move the stock and the CMO's sales are consistent with option exercise/tax planning. Monitor next 8-K or earnings for any fundamental catalyst, but this filing alone does not warrant a trade.
ALKS drugs
ALKS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 4 $46.10entry
- T+1 · 2mo ago −1.32%α −0.77% · $45.49
- T+5 · 2mo ago −0.59%α +0.62% · $45.83
- T+20 · 6w ago −7.25%α −7.85% · $42.76
- T+50 · todayOpen
- T+60 · in 14d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two senior Alkermes executives (EVP/CLO and EVP R&D/CMO) sold a combined $521K in open-market shares over a 3-day window. The CMO's sales followed derivative exercises, suggesting a tax/vesting-driven pattern rather than a purely bearish signal. At 0.0065% of Alkermes' $8.0B market cap, the dollar value is trivial and well below the 0.1% materiality threshold for insider clusters. This is a routine, non-informational cluster, no actionable signal for traders.
Key Financial Metrics
Key Facts
- Two senior executives sold shares totaling $521K in a 3-day window
- CMO Hopkinson sold 9K shares at $46.99 after exercising 10K options at $24.59 and $0, typical tax/vesting pattern
- CLO Gaffin sold 2K shares at $48.01, a small, likely routine sale
- Total sales represent 0.0065% of Alkermes' $8.0B market cap, far below the 0.1% materiality threshold
- No insider buying in the cluster to offset the sales
Financial Impact
Total insider sales of $521K represent 0.0065% of market cap, economically trivial
Risk Factors
- Insider sales could accelerate if the stock continues to rise, but current volume is immaterial
- No buying activity to offset the sales, a lack of bullish insider conviction
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ALKS-1788476477349 |
Track record
23 reports on ALKS
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +25.88% at T+60 after the May 12, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago 8-K Neutral 4/10 Entry $46.98 Now $46.53 −0.96% settles Feb 10
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $44.54 Now $46.53 +4.47% settles Feb 3
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $45.89 Now $46.53 +1.39% settles Feb 2
- Nov 3, 202613d ago 8-K Neutral 5/10 Entry $45.69 Now $46.53 +1.84% settles Feb 1
- Sep 21, 20268w ago 8-K Bullish 6/10 Entry $44.00 Now $46.53 +5.76% settles Dec 15
- Sep 16, 20268w ago 8-K Neutral 2/10 Entry $46.07 Now $46.53 +1.00% settles Dec 10
- Sep 3, 202610w ago Insider Cluster Neutral 2/10 Viewing Entry $46.10 Now $46.53 +0.93% settles Dec 1
- Aug 3, 202615w ago Insider Cluster Bearish 4/10 Entry $49.67 to $44.32 Now $46.53 +6.32% ▲ +10.77% +11.15% vs SPY
- Aug 3, 202615w ago Insider Cluster Neutral 2/10 Entry $49.67 to $44.32 Now $46.53 −6.32% ▼ −10.77% −11.15% vs SPY
- Aug 3, 202615w ago Insider Cluster Neutral 3/10 Entry $49.67 to $44.32 Now $46.53 −6.32% ▼ −10.77% −11.15% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers